|
Latest EMCDDA Reports:
The
latest UK Drug Report: United
Kingdom Drug Situation: 2005 edition
(PDF 1.5MB), provides a comprehensive overview of the drug situation in
the United Kingdom. Chapters cover the prevalence of drug use, legislative
changes, trends in prevention and treatment, drugs and crime, social correlates
of drug use, and many other new developments and trends.
Detailed
overviews of the drug phenomenon at national level for each of the countries
in the European Union, including the UK, in 2002, 2003 and 2004, can be
downloaded here
in PDF format
The
complete Annual
report 2005: The state of the drugs problem in Europe can be accessed
here
Please
note that the above links will take you to the EMCDDA website and will
open in a new window.
Quick
round up from EMCDDA report 2005 on the UK
- Spain
and UK reporting highest levels of cocaine use (general upward trend
across Europe), but most substantial rises occurred prior to 2001 and
recent data suggest that this is now levelling off
- Crack
cocaine limited across EU with significant use reported in few major
cities, principally in Netherlands and UK
- More Europeans
seeking treatment for cocaine-related problems
- Highest
percentage seeking help for cocaine use in Spain and Netherlands
- Highest
rates of ecstasy use among young adults in UK (6.9%), but use has now
stabilised
- Dennmark,
Estonia & UK hav highest rates of amphetamine use among young adults,
but UK is only country to report a significant fall in recent use of
amphetamine in this age group (15-34 yr olds)
- In 2003
amphetamine labs uncovered in UK
- Although
UK historically highest rates of cannabis use, situation has stabilised
since 1998 (19.5% recent use) and we are now fourth in Europe behind
Spain (19.5%), France (19.7%) and Czech Republic (22.1%)
- ESPAD:
in 1995 UK had highest prevalence of cannabis use among 15/16 yr olds
- by 2003 the rest of Europe had caught up while we had stabilised:
Czech republic(44%); Ireland 39%; UK 38%; France 38%; Slovenia 28%;
Italy 27% etc. Netherlands and UK reported small decrease in lifetime
prevalence for 15/16 yr olds, but at 1% too small a change to interpret
June
2006
|
